Healthcare provider profile · identity verified

Eman Wahba, MD

Internal Medicine · ROCHESTER, NY · NPI 1134127699

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	838	254
Amlodipine Besylate	Amlodipine Besylate	674	192
Levothyroxine Sodium	Levothyroxine Sodium	468	127
Lisinopril	Lisinopril	378	113
Rosuvastatin Calcium	Rosuvastatin Calcium	346	103
Hydrochlorothiazide	Hydrochlorothiazide	321	88
Losartan Potassium	Losartan Potassium	321	92
Simvastatin	Simvastatin	314	98
Metformin Hcl	Metformin Hcl	300	91
Omeprazole	Omeprazole	294	85
Metoprolol Succinate	Metoprolol Succinate	264	77
Pantoprazole Sodium	Pantoprazole Sodium	256	75
Gabapentin	Gabapentin	248	66
Albuterol Sulfate Hfa	Albuterol Sulfate	191	59
Sertraline Hcl	Sertraline Hcl	166	49
Zolpidem Tartrate	Zolpidem Tartrate	160	27
Metoprolol Tartrate	Metoprolol Tartrate	155	45
Alprazolam	Alprazolam	129	38
Famotidine	Famotidine	125	36
Trazodone Hcl	Trazodone Hcl	125	27
Allopurinol	Allopurinol	119	38
Meloxicam	Meloxicam	117	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	115	33
Fluticasone Propionate	Fluticasone Propionate	112	49
Metformin Hcl Er	Metformin Hcl	110	36
Pioglitazone Hcl	Pioglitazone Hcl	109	30
Potassium Chloride	Potassium Chloride	107	27
Duloxetine Hcl	Duloxetine Hcl	103	30
Torsemide	Torsemide	96	26
Paroxetine Hcl	Paroxetine Hcl	95	21
Atenolol	Atenolol	94	26
Lovastatin	Lovastatin	92	27
Celecoxib	Celecoxib	88	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	85	25
Clopidogrel	Clopidogrel Bisulfate	82	22
Ozempic	Semaglutide	82	14
Glimepiride	Glimepiride	80	16
Pravastatin Sodium	Pravastatin Sodium	76	25
Montelukast Sodium	Montelukast Sodium	75	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	25
Irbesartan	Irbesartan	73	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	12
Furosemide	Furosemide	67	24
Hydroxyzine Hcl	Hydroxyzine Hcl	65	22
Citalopram Hbr	Citalopram Hydrobromide	64	19
Donepezil Hcl	Donepezil Hcl	64	13
Tamsulosin Hcl	Tamsulosin Hcl	60	19
Terazosin Hcl	Terazosin Hcl	60	18
Labetalol Hcl	Labetalol Hcl	59	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	17
Fluoxetine Hcl	Fluoxetine Hcl	57	16
Alendronate Sodium	Alendronate Sodium	56	17
Eliquis	Apixaban	53	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	50	15
Benazepril Hcl	Benazepril Hcl	50	13
Venlafaxine Hcl Er	Venlafaxine Hcl	50	15
Carvedilol	Carvedilol	48	13
Lorazepam	Lorazepam	48	14
Spironolactone	Spironolactone	48	17
Diazepam	Diazepam	46	11
Glipizide Er	Glipizide	46	16
Glipizide	Glipizide	45	14
Jardiance	Empagliflozin	43	11
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	12
Lansoprazole	Lansoprazole	39	14
Azithromycin	Azithromycin	38	36
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	38	12
Solifenacin Succinate	Solifenacin Succinate	37	13
Fenofibrate	Fenofibrate	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Finasteride	Finasteride	35	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Meclizine Hcl	Meclizine Hcl	31	14
Rybelsus	Semaglutide	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	19
Amoxicillin	Amoxicillin	28	19
Bisoprolol Fumarate	Bisoprolol Fumarate	28	11
Januvia	Sitagliptin Phosphate	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	13
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Rivastigmine	Rivastigmine Tartrate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Piroxicam	Piroxicam	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	20
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Digoxin	Digoxin	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Verapamil Er	Verapamil Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Cimetidine	Cimetidine	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Prednisone	Prednisone	16	16
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	14	suppressed
Ramipril	Ramipril	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Baclofen	Baclofen	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Nadolol	Nadolol	12	suppressed
Nitroglycerin	Nitroglycerin	12	12
Trulicity	Dulaglutide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error